The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques
Abstract
C-reactive protein (CRP) is a predictor of cardiovascular risk. It circulates as a pentamer (pentameric CRP) in plasma. The in vivo existence of monomeric (m)CRP has been postulated, but its function and source are not clear. We show that mCRP is deposited in human aortic and carotid atherosclerotic plaques but not in healthy vessels. pCRP is found neither in healthy nor in diseased vessels. As source of mCRP, we identify a mechanism of dissociation of pCRP to mCRP. We report that activated platelets, which play a central role in cardiovascular events, mediate this dissociation via lysophosphatidylcholine, which is present on activated but not resting platelets. Furthermore, the dissociation of pCRP to mCRP can also be mediated by apoptotic monocytic THP-1 and Jurkat T cells. The functional consequence is the unmasking of proinflammatory effects of CRP as demonstrated in experimental settings that are pathophysiologically relevant for atherogenesis: compared to pCRP, mCRP induces enhanced monocyte chemotaxis; monocyte activation, as determined by conformational change of integrin Mac-1; generation of reactive oxygen species; and monocyte adhesion under static and physiological flow conditions. In conclusion, we demonstrate mCRP generation via pCRP dissociation on activated platelets and H 2 O 2 -treated apoptotic THP-1 and Jurkat T cells, thereby identifying a mechanism of localized unmasking of the proinflammatory properties of CRP. This novel mechanism provides a potential link between the established cardiovascular risk marker, circulating pCRP, and localized platelet-mediated inflammatory and proatherogenic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Jialal, I., Devaraj, S., & Venugopal, S. K. (2004) · Hypertension · doi:10.1161/01.hyp.0000130484.20501.df · Cited by 568
Calabró, P., Willerson, J. T., & Yeh, E. T. H. (2003) · Circulation · doi:10.1161/01.cir.0000096055.62724.c5 · Cited by 566
Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64051-5 · Cited by 564
Oei, H.-H. S., van der Meer, I. M., Hofman, A., Koudstaal, P. J., Stijnen, T., Breteler, M. M. B., & Witteman, J. C. M. (2005) · Circulation · doi:10.1161/01.cir.0000154553.12214.cd · Cited by 423
Biomarkers of Atherosclerotic Plaque Instability and Rupture
Koenig, W., & Khuseyinova, N. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251503.35795.4f · Cited by 418
Maier, W., Altwegg, L. A., Corti, R., Gay, S., Hersberger, M., Maly, F. E., Sütsch, G., Roffi, M., Neidhart, M., Eberli, F. R., et al. (2005) · Circulation · doi:10.1161/01.cir.0000158479.58589.0a · Cited by 297
Kim, S. J., Gershov, D., Ma, X., Brot, N., & Elkon, K. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020542 · Cited by 282
Khreiss, T., József, L., Potempa, L. A., & Filep, J. G. (2004) · Circulation · doi:10.1161/01.cir.0000125527.41598.68 · Cited by 278
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
Volanakis, J. E., & Wirtz, K. W. A. (1979) · Nature · doi:10.1038/281155a0 · Cited by 236
Lavi, S., McConnell, J. P., Rihal, C. S., Prasad, A., Mathew, V., Lerman, L. O., & Lerman, A. (2007) · Circulation · doi:10.1161/circulationaha.106.671420 · Cited by 229
O’Donoghue, M., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Cannon, C. P., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.612630 · Cited by 229
Unraveling the Mysteries of Phospholipid Scrambling
Wiedmer, T., & Sims, P. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616224 · Cited by 211
Ji, S., Wu, Y., Zhu, L., Potempa, L. A., Sheng, F., Lu, W., & Zhao, J. (2007) · The FASEB Journal · doi:10.1096/fj.06-6722com · Cited by 198
Venugopal, S. K., Devaraj, S., & Jialal, I. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62345-0 · Cited by 173
Inoue, T., Kato, T., Uchida, T., Sakuma, M., Nakajima, A., Shibazaki, M., Imoto, Y., Saito, M., Hashimoto, S., Hikichi, Y., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.029 · Cited by 168
Khreiss, T., József, L., Hossain, S., Chan, J. S. D., Potempa, L. A., & Filep, J. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205378200 · Cited by 167
C-Reactive Protein in Atherosclerotic Lesions
Sun, H., Koike, T., Ichikawa, T., Hatakeyama, K., Shiomi, M., Zhang, B., Kitajima, S., Morimoto, M., Watanabe, T., Asada, Y., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61202-3 · Cited by 166
Self-citationCritical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling
Arcaro, A., Aubert, M., del Hierro, M. E. E., Khanzada, U. K., Angelidou, S., Tetley, T. D., Bittermann, A. G., Frame, M. C., & Seckl, M. J. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.003 · Cited by 157
Khreiss, T., József, L., Potempa, L. A., & Filep, J. G. (2005) · Circulation Research · doi:10.1161/01.res.0000183881.11739.cb · Cited by 141
Fujii, H., Li, S., Szmitko, P. E., Fedak, P. W. M., & Verma, S. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242794.65541.02 · Cited by 136
Ji, S., Ma, L., Bai, C., Shi, J., Li, H., Potempa, L. A., Filep, J. G., Zhao, J., & Wu, Y. (2009) · The FASEB Journal · doi:10.1096/fj.08-116962 · Cited by 134
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement.
Volanakis, J. E., & Narkates, A. J. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.5.1820 · Cited by 133
C-Reactive Protein: Structure Affects Function
Verma, S., Szmitko, P. E., & Yeh, E. T. H. (2004) · Circulation · doi:10.1161/01.cir.0000127085.32999.64 · Cited by 126
C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth
Molins, B., Peña, E., Vilahur, G., Mendieta, C., SLEVIN, M. A., & Badimón, L. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.174359 · Cited by 116
Khreiss, T., József, L., Potempa, L. A., & Filep, J. G. (2004) · Circulation · doi:10.1161/01.cir.0000146846.00816.dd · Cited by 114
FcγRIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase
Mineo, C., Gormley, A. K., Yuhanna, I. S., Osborne-Lawrence, S. L., Gibson, L. L., Hahner, L., Shohet, R. V., Black, S., Salmon, J. E., Samols, D. R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000194323.77203.fe · Cited by 107
Meuwissen, M., van der Wal, A. C., Niessen, H. W. M., Koch, K. T., de Winter, R. J., van der Loos, C. M., Rittersma, S. Z. H., Chamuleau, S. A. J., Tijssen, J. G. P., Becker, A. E., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.027235 · Cited by 105
Zouki, C., Haas, B., Chan, J. S. D., Potempa, L. A., & Filep, J. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5355 · Cited by 101
Devaraj, S., Davis, B., Simon, S. I., & Jialal, I. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00150.2006 · Cited by 98
Perticarari, S., Presani, G., & Banfi, E. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90251-8 · Cited by 83
Singh, U. S., Devaraj, S., Dasu, M. R. K., Ciobanu, D. A., Reusch, J. E. B., & Jialal, I. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000241572.05292.fb · Cited by 74
Takeda, M., Shirato, I., Kobayashi, M., & Endou, H. (1999) · The Nephron journals/Nephron journals · doi:10.1159/000045282 · Cited by 66
Dissociation and Subunit Rearrangement of Membrane-Bound Human C-Reactive Proteins
Wang, H., & Sui, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5733 · Cited by 60
Devaraj, S., Venugopal, S. K., & Jialal, I. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.031 · Cited by 53
Eisenhardt, S. U., Schwarz, M., Schallner, N., Soosairajah, J., Bassler, N., Huang, D., Bode, C., & Peter, K. (2006) · Blood · doi:10.1182/blood-2006-03-007179 · Cited by 48
Self-citationC-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes
Xie, L., Chang, L., Guan, Y., & Wang, X. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000183568.48389.a1 · Cited by 32
Evidence for a differential functional regulation of the two β3-integrins αVβ3 and αIIbβ3
Ahrens, I., Moran, N. M., Aylward, K., Meade, G., Moser, M. J., Assefa, D., Fitzgerald, D. J., Bode, C., & Peter, K. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.036 · Cited by 27
Self-citation
Cited by
Stroke risk factors, genetics, and prevention
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952
“ple, interacts with other immune mediators to activate platelets and complement proteins.(153) Functionally, each CRP monomeric”
BackgroundPlatelets, inflammation and tissue regeneration
Nurden, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0720 · Cited by 791
High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Yousuf, O., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.016 · Cited by 494
Luan, Y.-Y., & Yao, Y.-M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01302 · Cited by 396
C-Reactive Protein in Atherothrombosis and Angiogenesis
Badimon, L., Peña, E., Arderiu, G., Padró, T., Slevin, M., Vilahur, G., & Chiva-Blanch, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00430 · Cited by 323
Metadata
- Authors
- Eisenhardt, S. U., Habersberger, J., Murphy, A., Chen, Y.-C., Woollard, K. J., Bassler, N., Qian, H., von zur Muhlen, C., Hagemeyer, C. E., Ahrens, I., Chin-Dusting, J., Bobik, A., & Peter, K.
- Venue
- Circulation Research
- Published
- 2009-07-17
- Volume
- 105
- Issue
- 2
- Pages
- 128-137
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2026281835
- Cited by
- 272
- References
- 43
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.